Pharmacy Essentials for HIV Pre-Exposure Prophylaxis
  • CME

This CME/CPE-certified activity provides a comprehensive overview of HIV PrEP service provision from assessing patient eligibility to regimen administration and monitoring, with a primary focus on the role of pharmacists in expanding PrEP access and uptake for individuals at high risk of acquiring HIV infection.
John Faragon, PharmD, BCPS, AAHIVP
Program Director
Christina M. Madison, PharmD, FCCP, BCACP, AAHIVP
Physicians: maximum of 1.0 AMA PRA Category 1 Credit
Pharmacists: 1.0 contact hour (0.1 CEUs)
Released: December 14, 2018 Expiration: December 13, 2019
Multimedia Pharmacy Essentials for HIV Pre-Exposure Prophylaxis
This program is divided into short segments. After reviewing all segments, click the Claim Credit button to complete the CME posttest and evaluation.
Introduction to PrEP
Review the current status of the HIV epidemic in the United States and where PrEP fits into the HIV preventive care continuum
Launch Introduction to PrEP
PrEP Eligibility Guidelines
Learn the most important information from national guidelines on how to help patients determine if they are eligible for PrEP and if it could help protect them from HIV infection
Launch PrEP Eligibility Guidelines
PrEP Efficacy
Find out how effective PrEP is at preventing HIV infection among different populations and the important role of therapy adherence in maximizing prevention efficacy
Launch PrEP Efficacy
PrEP Initiation and On-Treatment Monitoring
Gain a thorough understanding of the work-up needed before patients can initiate PrEP, how PrEP is administered, and how patients should be monitored during PrEP therapy
Launch PrEP Initiation and On-Treatment Monitoring
The Role of the Pharmacist in PrEP Services
Consider the many important services that pharmacists can provide in helping to overcome barriers to PrEP access and uptake by individuals who are most at risk for HIV infection
Launch The Role of the Pharmacist in PrEP Services
PrEP in Special Populations
Review critical aspects of PrEP provision for at-risk patients in specific populations including adolescents, pregnant women, and transgender persons
Launch PrEP in Special Populations

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Apply expert guidelines in screening and identifying appropriate candidates for PrEP in the pharmacy setting
  • Provide insightful counsel to patients who are candidates for PrEP, including education on all aspects of PrEP and linkage to care resources as needed
  • Implement pharmacy-based strategies to support patients receiving PrEP, including confidential patient counseling, prescribing and/or dispensing, and on-therapy monitoring

Acknowledgements

Provided by the Annenberg Center for Health Sciences at Eisenhower
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Supported by educational grants from
Gilead Sciences, Inc.
ViiV Healthcare

Information on this Educational Activity

The Annenberg Center assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Program Director

John Faragon, PharmD, BCPS, AAHIVP

Pharmacist, HIV and HCV Medicine
Albany Medical Center
Regional Pharmacy Director
Northeast/Caribbean AIDS Education and Training Center (AETC)
Albany, New York

John Faragon, PharmD, BCPS, AAHIVP, has disclosed that he has received fees for non-CME/CE services from AbbVie, Gilead Sciences, Janssen, and Merck.

Faculty

Christina M. Madison, PharmD, FCCP, BCACP, AAHIVP

Associate Professor of Pharmacy Practice
Roseman University of Health Sciences
Henderson, Nevada

Christina M. Madison, PharmD, FCCP, BCACP, AAHIVP, has disclosed that she has served on the community speaker bureau for Janssen Therapeutics.

Staff

Jennifer Blanchette, PhD

Senior Scientific Director

Jennifer M. Blanchette, PhD, has no real or apparent conflicts of interest.
Jenny Schulz, PhD

Director, Scientific Services

Jenny Schulz, PhD, has no real or apparent conflicts of interest.
Anna Poppa

Editorial Contributor

Anna Poppa has no real or apparent conflicts of interest.

The PIM planners and managers have nothing to disclose.

Charles E. Willis, Director of Continuing Education from the Annenberg Center for Health Sciences at Eisenhower consults for Pfizer, Inc.; Amanda Sewell, MBA, Manager of Continuing Education and Melissa Velasquez, Accreditation Specialist both from the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Annenberg Center, Postgraduate Institute for Medicine (PIM), Clinical Care Options, and activity supporters do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Annenberg Center, PIM, Clinical Care Options, and activity supporters. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This program is intended for US pharmacists and other healthcare providers who care for patients with or at risk of HIV and HCV infection.

Goal

The goal of this activity is to improve pharmacists’ competence in contributing to the prevention and management of HIV and HCV infection.

Physician Continuing Medical Education

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Pharmacist Continuing Education

Accreditation Statement

The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation

This program is assigned ACPE Universal Activity 0797-9999-18-225-H02-P. This program is designated for up to 1.0 contact hour (0.1 CEUs) of continuing pharmacy education credit.

Type of Activity Application

For Pharmacists: Upon successfully completing the post-test with a score of 65% or better and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from December 14, 2018, through December 13, 2019:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Related Content

Karine Lacombe, MD, PhD, commentary on results from 2 randomized trials evaulating INSTI initation during pregnancy from CROI 2019 and potential implications for HIV care in France

Karine Lacombe, MD, PhD Released: July 18, 2019

Preview of IAS 2019 data from Mexico; phase III BRIGHTE, ADVANCE, GEMINI, TANGO, DISCOVER trials, and prevention and treatment in special populations.

Anton L. Pozniak, MD, FRCP Released: July 16, 2019

Slideset from CCO on HIV perspectives in Europe, challenging case discussions from Chloe Orkin, Juergen Rockstroh, Esteban Martinez.

Released: July 10, 2019

Drs. David Hardy and Daniel Kuritzkes provide CME/CE-certified analysis of the 2019 Conference on Retroviruses and Opportunistic Infections (CROI) as reported by Clinical Care Options (CCO)

W. David Hardy, MD Daniel R. Kuritzkes, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: June 13, 2019 Expiration: June 12, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?